These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 9224908

  • 1. Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response.
    Maes M, Verkerk R, Vandoolaeghe E, Van Hunsel F, Neels H, Wauters A, Demedts P, Scharpé S.
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(3):154-61. PubMed ID: 9224908
    [Abstract] [Full Text] [Related]

  • 2. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers.
    Maes M, Smith R, Christophe A, Vandoolaeghe E, Van Gastel A, Neels H, Demedts P, Wauters A, Meltzer HY.
    Acta Psychiatr Scand; 1997 Mar; 95(3):212-21. PubMed ID: 9111854
    [Abstract] [Full Text] [Related]

  • 3. Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers.
    Maes M, De Meester I, Verkerk R, De Medts P, Wauters A, Vanhoof G, Vandoolaeghe E, Neels H, Scharpé S.
    Psychoneuroendocrinology; 1997 Feb; 22(2):65-78. PubMed ID: 9149329
    [Abstract] [Full Text] [Related]

  • 4. Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process.
    Maes M, Van de Vyvere J, Vandoolaeghe E, Bril T, Demedts P, Wauters A, Neels H.
    J Affect Disord; 1996 Sep 09; 40(1-2):23-33. PubMed ID: 8882911
    [Abstract] [Full Text] [Related]

  • 5. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness.
    Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R.
    Biol Psychiatry; 1997 Sep 01; 42(5):349-58. PubMed ID: 9276075
    [Abstract] [Full Text] [Related]

  • 6. Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression.
    Maes M, Meltzer HY, Scharpé S, Bosmans E, Suy E, De Meester I, Calabrese J, Cosyns P.
    Psychiatry Res; 1993 Nov 01; 49(2):151-65. PubMed ID: 7908745
    [Abstract] [Full Text] [Related]

  • 7. Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments.
    Van Hunsel F, Wauters A, Vandoolaeghe E, Neels H, Demedts P, Maes M.
    Psychiatry Res; 1996 Dec 20; 65(3):159-69. PubMed ID: 9029664
    [Abstract] [Full Text] [Related]

  • 8. Disturbances in dexamethasone suppression test and lower availability of L-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy.
    Maes M, Claes M, Schotte C, Delbeke L, Jacquemyn Y, Verkerk R, De Meester I, Scharpé S.
    J Psychosom Res; 1992 Feb 20; 36(2):191-7. PubMed ID: 1560430
    [Abstract] [Full Text] [Related]

  • 9. Increased plasma levels of competing amino acids, rather than lowered plasma tryptophan levels, are associated with a non-response to treatment in major depression.
    Ormstad H, Dahl J, Verkerk R, Andreassen OA, Maes M.
    Eur Neuropsychopharmacol; 2016 Aug 20; 26(8):1286-96. PubMed ID: 27237997
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma tryptophan and five other amino acids in depressed and normal subjects.
    DeMyer MK, Shea PA, Hendrie HC, Yoshimura NN.
    Arch Gen Psychiatry; 1981 Jun 20; 38(6):642-6. PubMed ID: 7247626
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the relative potency of individual competing amino acids to tryptophan transport in endogenously depressed patients.
    Møller SE.
    Psychiatry Res; 1980 Oct 20; 3(2):141-50. PubMed ID: 6947307
    [Abstract] [Full Text] [Related]

  • 13. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.
    Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H.
    Cytokine; 1997 Nov 20; 9(11):853-8. PubMed ID: 9367546
    [Abstract] [Full Text] [Related]

  • 14. Immune disorders in depression: higher T helper/T suppressor-cytotoxic cell ratio.
    Maes M, Stevens W, DeClerck L, Bridts C, Peeters D, Schotte C, Cosyns P.
    Acta Psychiatr Scand; 1992 Dec 20; 86(6):423-31. PubMed ID: 1281959
    [Abstract] [Full Text] [Related]

  • 15. Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism.
    Maes M, Wauters A, Verkerk R, Demedts P, Neels H, Van Gastel A, Cosyns P, Scharpé S, Desnyder R.
    Neuropsychopharmacology; 1996 Sep 20; 15(3):243-51. PubMed ID: 8873107
    [Abstract] [Full Text] [Related]

  • 16. Tryptophan to competing amino acids ratio in depressive disorder: relation to efficacy of antidepressive treatments.
    Møller SE.
    Acta Psychiatr Scand Suppl; 1985 Sep 20; 325():3-31. PubMed ID: 2418637
    [Abstract] [Full Text] [Related]

  • 17. Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response.
    Maes M, Scharpé S, Meltzer HY, Okayli G, Bosmans E, D'Hondt P, Vanden Bossche BV, Cosyns P.
    Psychiatry Res; 1994 Nov 20; 54(2):143-60. PubMed ID: 7761549
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma tryptophan levels and plasma tryptophan/neutral amino acids ratio in patients with mood disorder, patients with obsessive-compulsive disorder, and normal subjects.
    Lucca A, Lucini V, Piatti E, Ronchi P, Smeraldi E.
    Psychiatry Res; 1992 Nov 20; 44(2):85-91. PubMed ID: 1480681
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.